FARMAK Farmak was included in the ranking of the best enterprises according to the CSR Index 2023, which determines the sustainability of Ukrainian businesses during the war. The study was conducted by the expert organization CSR Ukraine and the online publication The Page.
The rating also includes the following companies: Nova Poshta, Kyivstar, PUMB, Deloitte, Kernel, MHP, EPAM, Infopulse, Sense Bank, and others.
The assessment of businesses was carried out according to the 5-component model of CSR in wartime, which included the following points: business continuity and payment of taxes, employee safety, capability, unity, and community.
Farmak is one of the largest taxpayers in the country's pharmaceutical industry, which constantly fulfills its obligations to the state. Even before the outbreak of a full-scale war, the company began investing in the construction of shelters to ensure the safety of its employees. Since February 2022, it has allocated more than UAH 90 million to help the Armed Forces of Ukraine and Ukrainians affected by the war. It also implements social projects in support of communities on an ongoing basis. Among the examples of social initiatives of the company:
- Project "Farmak. Light for Life", was aimed at improving road safety for young pedestrians in blackout conditions. As part of the project, the company donated more than 7,000 reflective bracelets to students of Shostka City.
- Farmak supports the charitable initiative Seeds for Ukraine. The main goal of the project is to provide farmers with seeds so that they can grow their own crops and avoid food crises in Ukraine during the war.
- The company joined the "Safe Education" initiative, which builds and equips reliable bomb shelters in Ukrainian educational institutions. The company allocated one million hryvnias to create modern comfortable shelters in the Factory Lyceum in the Sumy region, the Romano-Germanic gymnasium No. 123, and the specialized school "Malysh" in Kyiv, as well as in the Nemyrinets school in the Zhytomyr region.
- Recently, Farmak took care of the health of little Ukrainians by donating vitamin complexes to more than 20,000 children who found themselves in difficult life situations. The initiative was aimed at helping orphans, children from internally displaced families, and other children in need of support.
"During the war, when the country is going through difficult times, understanding and observing the principles of social responsibility is extremely important for big business. When we support each other, we become stronger. Therefore, for our company, supporting social programs and charitable initiatives is a duty. These programs are even more relevant as they help the military, war-affected children, and people who find themselves in economic hardship due to the war. Although the war gave rise to many problems in society, if every business invests in solving them, we will be able to overcome crises much faster," notes Yevgeniya Piddubna, Director for Corporate Communications at Farmak.
The European Business Association (EBA) has recognized companies that fearlessly move forward and succeed even during the war in Ukraine. Among them, the leader of the Ukrainian pharmaceutical market* Farmak, which joined the EBA in 2015, also received a distinction. The European Business Association is the largest association of foreign, European and domest...
In the first days of the tragedy, after the explosion of the Kakhovka Hydroelectric Power Plant by Russian terrorists, we sent painkillers, anti-inflammatories, antifungals, and other medicines to the Kherson region, which were urgently needed for the treatment of the victims. Medicines were sent to the Ivan Horbachevsky Kherson Regional Infectious Diseases ...
The pharmaceutical sector has been strictly adhering to the strategic vector of European integration for several years in a row. An important component of this process is the mutual recognition of GMP (Good Manufacturing Practice) certificates between the EU and Ukraine. Today, within the framework of the PharmaExport conference, representatives of the pharm...
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Farmak PAT published this content on 04 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 July 2023 12:33:05 UTC.
